Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease

被引:26
作者
Svedberg, Marie M. [1 ,2 ]
Rahman, Obaidur [3 ]
Hall, Hakan [1 ,2 ]
机构
[1] Uppsala Univ, Dept Med Chem, Preclin PET Platform, SE-75183 Uppsala, Sweden
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, SE-75183 Uppsala, Sweden
[3] Oslo Univ Hosp, Norwegian Med Cyclotron Ctr, Oslo, Norway
关键词
Alzheimer's disease; Amyloid plaques; Molecular imaging; Positron emission tomography; Preclinical evaluation; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; PET IMAGING AGENTS; TRANSGENIC ANIMAL-MODELS; THIOFLAVIN-T-BINDING; IN-VIVO DETECTION; MOUSE MODEL; MONOCLONAL-ANTIBODY; STILBENE DERIVATIVES;
D O I
10.1016/j.nucmedbio.2011.10.007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Visualizing the neuropathological hallmarks amyloid plaques and neurofibrillary tangles of Alzheimer's disease in vivo using positron emission tomography (PET) or single photon emission computed tomography will be of great value in diagnosing the individual patient and will also help in our understanding of the disease. The successful introduction of [C-11]PIB as a PET tracer for the amyloid plaques less than 10 years ago started an intensive research, and numerous new compounds for use in molecular imaging of the amyloid plaques have been developed. The candidates are based on dyes like thioflavin T, Congo red and chrysamine G, but also on other types such as benzoxazoles, curcumin and stilbenes. In the present review, we present methods of the radiochemistry and preclinical evaluation as well as the main properties of some of these compounds. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:484 / 501
页数:18
相关论文
共 128 条
[51]   The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation [J].
Klunk, William E. ;
Mathis, Chester A. .
CURRENT OPINION IN NEUROLOGY, 2008, 21 (06) :683-687
[52]   Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging [J].
Koole, Michel ;
Lewis, Dewi M. ;
Buckley, Christopher ;
Nelissen, Natalie ;
Vandenbulcke, Mathieu ;
Brooks, David J. ;
Vandenberghe, Rik ;
Van Laere, Koen .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (05) :818-822
[53]  
Koronyo-Hamaoui M, 2010, NEUROIMAGE
[54]   The binding of thioflavin-T to amyloid fibrils: localisation and implications [J].
Krebs, MRH ;
Bromley, EHC ;
Donald, AM .
JOURNAL OF STRUCTURAL BIOLOGY, 2005, 149 (01) :30-37
[55]   2-(2-[2-dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: A novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients [J].
Kudo, Yukitsuka ;
Okamura, Nobuyuki ;
Furumoto, Shozo ;
Tashiro, Manabu ;
Furukawa, Katsutoshi ;
Maruyama, Masahiro ;
Itoh, Masatoshi ;
Iwata, Ren ;
Yanai, Kazuhiko ;
Arai, Hiroyuki .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) :553-561
[56]   Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease [J].
Kudo, Yukitsuka .
MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2006, 15 (04) :209-213
[57]   Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease [J].
Kung, MP ;
Hou, C ;
Zhuang, ZP ;
Skovronsky, D ;
Kung, HF .
BRAIN RESEARCH, 2004, 1025 (1-2) :98-105
[58]   Characterization of IMPY as a potential imaging agent for β-amyloid plaques in double transgenic PSAPP mice [J].
Kung, MP ;
Hou, C ;
Zhuang, ZP ;
Cross, AJ ;
Maier, DL ;
Kung, HF .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (08) :1136-1145
[59]   IMPY:: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques [J].
Kung, MP ;
Hou, C ;
Zhuang, ZP ;
Zhang, B ;
Skovronsky, D ;
Trojanowski, JQ ;
Lee, VMY ;
Kung, HF .
BRAIN RESEARCH, 2002, 956 (02) :202-210
[60]   In vitro imaging techniques in Neurodegenerative diseases [J].
Langstrom, Bengt ;
Andren, Per E. ;
Lindhe, Orjan ;
Svedberg, Marie ;
Hall, Hakan .
MOLECULAR IMAGING AND BIOLOGY, 2007, 9 (04) :161-175